04th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190022009 | PROCESS FOR OBTAINING A BIOPOLIMERIC HEMOSTATIC POWDER AND THE PRODUCT | 2019-01-24 |
20190022010 | PROCESS OF PREPARING ACTIVE PHARMACEUTICAL INGREDIENT SALTS | 2019-01-24 |
20190022011 | TABLETS HAVING DISCONTINUOUS COATED REGIONS | 2019-01-24 |
20190022012 | METHOD FOR THE PRODUCTION OF A PHARMACEUTICAL DELIVERY SYSTEM | 2019-01-24 |
20190022013 | SOFT-CHEW TABLET PHARMACEUTICAL FORMULATIONS | 2019-01-24 |
20190022014 | Enteric coated oral pharmaceutical preparation comprising dimethyl fumarate | 2019-01-24 |
20190022015 | INGESTIBLE MEDICAL DELIVERY DEVICES | 2019-01-24 |
20190022016 | COMPOSITIONS FOR SUSTAINED RELEASE OF ANTI-GLAUCOMA AGENTS TO CONTROL INTRAOCULAR PRESSURE | 2019-01-24 |
20190022017 | USE OF DECELLULARIZED EXTRACELLULAR MATRIX FOR ENCAPSULATING CELLS | 2019-01-24 |
20190022018 | Biomembrane, Closed Structure with Biomembrane Characteristics or Cellular Compartment Derived from Natural Sources and/or Self-Assembly Techniques, Preparation Method and Applications Thereof | 2019-01-24 |
20190022019 | POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASE | 2019-01-24 |
20190022020 | NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT | 2019-01-24 |
20190022021 | OXYGEN-GENERATING COMPOSITIONS FOR ENHANCING CELL AND TISSUE SURVIVAL IN VIVO | 2019-01-24 |
20190022022 | PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION | 2019-01-24 |
20190022023 | ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS | 2019-01-24 |
20190022024 | TRANSDERMAL PATCH | 2019-01-24 |
20190022025 | TRANSDERMAL PATCH | 2019-01-24 |
20190022026 | Once-A-Day Replacement Transdermal Administration Of Fentanyl | 2019-01-24 |
20190022027 | REPROGRAMMING-BASED MODELS OF NEURODEVELOPMENTAL DISORDERS AND USES THEREOF | 2019-01-24 |
20190022028 | CANNABIDIOL-ENRICHED CAPRYLIC ACID | 2019-01-24 |
20190022029 | Formulation and Process for Modulating Wound Healing | 2019-01-24 |
20190022030 | EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE AND AMITRIPTYLINE HYDROCHLORIDE | 2019-01-24 |
20190022031 | EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE AND AMITRIPTYLINE HYDROCHLORIDE | 2019-01-24 |
20190022032 | SELECTIVE KILLING OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES | 2019-01-24 |
20190022033 | TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS | 2019-01-24 |
20190022034 | PHARMACEUTICAL SOLUTION COMPRISING DOPAMINE FOR USE IN TREATING PARKINSON'S DISEASE | 2019-01-24 |
20190022035 | COMPOSITIONS, METHODS AND DEVICES FOR FORMING IMPLANTS FROM INJECTED LIQUIDS | 2019-01-24 |
20190022036 | CAPSAICIN SEQUENTIAL DOSING METHOD FOR TREATMENT OF MORTON'S NEUROMA PAIN | 2019-01-24 |
20190022037 | CHEMICAL MOLECULES THAT INHIBIT THE SLICING MECHANISM FOR TREATING DISEASES RESULTING FROM SPLICING ANOMALIES | 2019-01-24 |
20190022038 | COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES | 2019-01-24 |
20190022039 | COMPOUND HAVING ENHANCING ACTIVITY FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIONS | 2019-01-24 |
20190022040 | VALPROATE AS A TOPICAL ANTI-FUNGAL TREATMENT | 2019-01-24 |
20190022041 | OIL PALM PHENOLICS COMPOSITION FOR THE PROTECTION OF HUMANS, ORGANS, CELLS AND TISSUES AGAINST THE INJURIOUS EFFECTS OF EXPOSURE TO IONIZING RADIATION | 2019-01-24 |
20190022042 | EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF | 2019-01-24 |
20190022043 | METHODS OF USING CASPASE INHIBITORS IN TREATMENT OF LIVER DISEASE | 2019-01-24 |
20190022044 | SALTS OF 5-AMINOLEVULINIC ACID AND DERIVATIVES | 2019-01-24 |
20190022045 | MARINE ORGANISM-DERIVED EXTRACT, COMPOUND, AND MEDICAL COMPOSITION HAVING NICHE FORMATION SUPPRESSING ACTIVITY OF LEUKEMIC STEM CELLS | 2019-01-24 |
20190022046 | Compositions, Methods and/or Devices for Prevention and/or Treatment of Dry Eye Disorders | 2019-01-24 |
20190022047 | COMPOSITION CONTAINING MONOACETYLDIACYLGLYCEROL COMPOUND AS ACTIVE INGREDIENT FOR INHIBITING BLOOD CANCER OR METASTASIS | 2019-01-24 |
20190022048 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | 2019-01-24 |
20190022049 | HYDROQUINONE COMPOUNDS, PREPARATION METHODS THEREFOR, AND USE IN ANTI-TUMOR OR IMMUNOMODULATION THERAPY | 2019-01-24 |
20190022050 | FORMULATION FOR THE TREATMENT OF ACNE | 2019-01-24 |
20190022051 | METHODS OF TREATING AN OVERWEIGHT OR OBESE SUBJECT | 2019-01-24 |
20190022052 | NEURODEVELOPMENTAL DISORDER THERAPY | 2019-01-24 |
20190022053 | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) | 2019-01-24 |
20190022054 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND MITIGATION OF ANTIDEPRESSANT DEPENDENDANCE AND WITHDRAWAL | 2019-01-24 |
20190022055 | FOOD BASED DELIVERY OF CANNABINOIDS | 2019-01-24 |
20190022056 | POLYPHENOL-REACTIVE OXYGEN SPECIES COMPOSITIONS AND METHODS | 2019-01-24 |
20190022057 | USE OF DAPHNORETIN IN THE PREVENTION OF TISSUE OR ORGAN TRANSPLANT REJECTION OR GRAFT-VERSUS-HOST-DISEASE | 2019-01-24 |
20190022058 | MICROCAPSULES CONTAINING AN OXIDIZABLE ACTIVE, AND A PROCESS FOR PREPARING THE SAME | 2019-01-24 |
20190022059 | LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO GENERATE BIOCOMPATIBLE OPHTHALMIC FORMULATIONS | 2019-01-24 |
20190022060 | COMPOUNDS AND METHODS FOR THE TREATMENT OF MICROBIAL INFECTIONS | 2019-01-24 |
20190022061 | Statins (Atorvastatin) can lower blood sugar level in diabetic | 2019-01-24 |
20190022062 | USES OF INDOLINONE COMPOUNDS | 2019-01-24 |
20190022063 | NEW USE | 2019-01-24 |
20190022064 | PRMT1 Inhibitors and Uses Thereof | 2019-01-24 |
20190022065 | PHARMACEUTICAL COMPOSITION COMPRISING BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVE OR SALT THEREOF AND PREPARATION METHOD THEREOF | 2019-01-24 |
20190022066 | PYRAZOLE DERIVATIVES AND THEIR USES THEREOF | 2019-01-24 |
20190022067 | METHOD OF RESTORING ANALGESIC EFFICACY OF ALPHA2-ADRENOCEPTOR AGONISTS IN NEUROPATHIC PAIN TREATMENT | 2019-01-24 |
20190022068 | TRPM8 RECEPTOR AGONIST COMPOUNDS AND USES THEREOF | 2019-01-24 |
20190022069 | EPOTHILONE ANALOGS, METHODS OF SYNTHESIS, METHODS OF TREATMENT, AND DRUG CONJUGATES THEREOF | 2019-01-24 |
20190022070 | COMPOSITIONS AND METHODS FOR TREATING PLASMA CELL DISORDERS AND B-CELL PROLYMPHOCYTIC DISORDERS | 2019-01-24 |
20190022071 | METHODS OF TREATING PULMONARY DISEASES AND DISORDERS | 2019-01-24 |
20190022072 | USAGE OF ACETAZOLAMIDE FOR TREATING ICH, PARTICULARLY HYPERGLYCEMIC ICH | 2019-01-24 |
20190022073 | PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR DERIVATIVE THEREOF | 2019-01-24 |
20190022074 | COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE | 2019-01-24 |
20190022075 | USE OF OLIGOPYRIDYLAMIDES TO INHIBIT MUTANT P53 AMYLOID FORMATION AND RESTORE ITS TUMOR SUPPRESSOR FUNCTION | 2019-01-24 |
20190022076 | SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION | 2019-01-24 |
20190022078 | NOVEL COMPOUNDS AS REARRANGED DURING TRANSFECTION (RET) INHIBITORS | 2019-01-24 |
20190022079 | METHOD OF TREATING PROSTATE CANCER | 2019-01-24 |
20190022080 | CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR | 2019-01-24 |
20190022081 | METHODS FOR SOLID TUMOR TREATMENT | 2019-01-24 |
20190022082 | Use Of Quinoline Derivatives For Treating Oesophageal Cancer And Treatment Method, Pharmaceutical Composition And Kit Thereof | 2019-01-24 |
20190022083 | USE OF LOW DOSE EMETINE FOR INHIBITION OF HUMAN CYTOMEGALOVIRUS (HCMV) | 2019-01-24 |
20190022084 | PROMOTING AXON RENEGERATION IN THE ADULT CNS THROUGH CONTROL OF PROTEIN TRANSLATION | 2019-01-24 |
20190022085 | SUSTAINED-RELEASE BUPRENORPHINE SOLUTIONS | 2019-01-24 |
20190022086 | CONTROLLED RELEASE HYDROCODONE FORMULATIONS | 2019-01-24 |
20190022087 | TREATMENT OF JOINT CONDITIONS | 2019-01-24 |
20190022088 | USE OF WX-UK1 AND ITS PRODRUG, WX-671, FOR THE TREATMENT OF NON-CANCEROUS MEDICAL CONDITIONS | 2019-01-24 |
20190022089 | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS | 2019-01-24 |
20190022090 | USE OF SULFONAMIDE INHIBITORS OF BCL-2 AND BCL-XL TO TREAT OPHTHALMIC DISEASE BY SELECTIVELY REMOVING SENESCENT CELLS | 2019-01-24 |
20190022091 | METHOD OF TREATMENT FOR MENTAL DISORDERS | 2019-01-24 |
20190022092 | Therapeutic Combinations of a BTK Inhibitor and a GITR Binding Molecule, a 4-1BB Agonist, or an OX40 Agonist | 2019-01-24 |
20190022093 | SMALL MOLECULE INHIBITORS OF THE NUCLEAR TRANSLOCATION OF ANDROGEN RECEPTOR FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER | 2019-01-24 |
20190022094 | COMPOSITIONS AND METHODS FOR INHIBITING DKK-1 | 2019-01-24 |
20190022095 | CERITINIB FORMULATION | 2019-01-24 |
20190022096 | METHODS OF TREATING CANCER | 2019-01-24 |
20190022097 | MOLECULAR TARGETS FOR THE TREATMENT OF WOUNDS, IN PARTICULAR CHRONIC WOUNDS | 2019-01-24 |
20190022098 | RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION | 2019-01-24 |
20190022099 | METHYLENE-TETRAHYDROFOLATE REDUCTASE ISOFORM-BASED BIOMARKER AND METHOD OF USE THEREOF | 2019-01-24 |
20190022100 | ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF | 2019-01-24 |
20190022101 | Treating Cochlear Synaptopathy | 2019-01-24 |
20190022102 | BETA-LACTAMASE INHIBITORS AND USES THEREOF | 2019-01-24 |
20190022103 | NEW METAL COMPLEXES OF NOCARDAMINE AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | 2019-01-24 |
20190022104 | APPLICATION OF PIRENZEPINE FOR TREATING SEPSIS | 2019-01-24 |
20190022105 | TREATMENT OF MIGRAINES | 2019-01-24 |
20190022106 | DRY POWDER FOR INHALATION | 2019-01-24 |
20190022107 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | 2019-01-24 |
20190022108 | PHARMACEUTICAL COMPOSITION | 2019-01-24 |
20190022109 | MULTIPHASIC CONTRACEPTIVE REGIMEN FOR ORAL COMBINATION DRUG FORMULATION OF PROGESTIN AND ESTROGEN | 2019-01-24 |